We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MULTIPLE cGMP VIOLATIONS DRAW WARNING FOR DRUGMAKER
MULTIPLE cGMP VIOLATIONS DRAW WARNING FOR DRUGMAKER
May 19, 2004
A manufacturer of Rx cough/cold combination products has been cited by the FDA for multiple current good manufacturing practice (cGMP) violations at its Somerset, N.J., facility.